Filing Details
- Accession Number:
- 0001883850-24-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-01 16:00:53
- Reporting Period:
- 2024-01-02
- Accepted Time:
- 2024-05-01 16:00:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226690 | George Yancopoulos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Bd. Co-Chair, President & Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-02 | 16,848 | $900.00 | 180,000 | No | 4 | S | Indirect | By Trust for Chldn. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust for Chldn. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 752,486 | Direct | |
| Common Stock | 5,889 | Indirect | By 401(k) Plan |
| Common Stock | 121,071 | Indirect | by 2022 GRAT I |
| Common Stock | 158,410 | Indirect | by 2022 GRAT II |
Footnotes
- Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022.
- As investment trustee of trusts for the benefit of the reporting person's children.
Billionaire Hedge Funds
